- alle zwei WochenErscheinungsrhythmus
- 46 mintypische Länge
- vor 3 Tagenletzte Folge
On The Bioinformatics CRO Podcast, we sit down with scientists to discuss interesting topics across biomedical research and to explore what made them who they are today.
Folgen
Tom Weaver - CellCodex and building biotech companies
Tom Weaver, scientist, serial entrepreneur, and co-founder and chairman of CellCodex, discusses his career building biotechnology companies, the importance of translating scientific innovation into successful products, and the potential of
Cooper Stansbury - cellular reprogramming
Cooper Stansbury, Senior Director of Scientific Operations at iReprogram, discusses the science behind cellular reprogramming and iReprogram's goal to make cell state programmable. The Bioinformatics CRO serves the computational biology nee
Michael Fanous - Scanimus
Michael Fanous, founder and CEO of FanousPhotonics, discusses imaging systems for pathology and Scanimus, a research-use only hybrid microscope scanner system. The Bioinformatics CRO serves the computational biology needs of academic resear
Trevor Nicks - biological compute
Trevor Nicks, founder and CEO of Caravel Bio, discusses biological compute, protein spores, and how to leverage intrinsic biological properties for protein engineering. The Bioinformatics CRO serves the computational biology needs of academ
Shannan Ho Sui - bioinformatics core facilities
Shannan Ho Sui, Principal Research Scientist in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health and Director of the Harvard Chan Bioinformatics Core, discusses what bioinformatics core facilities do and how
Zameel Cader - cell models for translational neuroscience
Professor Zameel Cader, a clinician scientist and Professor of Neuroscience and Neurology at Oxford University, discusses his work at the intersection of headache and pain disorders, human genetics, induced pluripotent stem cell models, blo
Adam Woolfe - antibody discovery technology
Dr. Adam Woolfe, computational biologist and bioinformatics R&D leader at Bio-Rad, discusses building bioinformatics tools for scientific instruments and new approaches to antibody discovery. The Bioinformatics CRO is a fully distributed co
Beth Cimini - bioimage analysis
Beth Cimini, leader of the Cimini Lab within the Imaging Platform at the Broad Institute of MIT and Harvard, discusses her work at the intersection of microscopy, computational biology, open source software, and scientific community buildin
Ben Langmead - pangenomics
Dr. Ben Langmead, professor of computer science at Johns Hopkins, director of the Langmead Lab, and founder and principal of InOrder Labs, tells us about his work building tools and resources for life scientists and his current focus on pan
Elliott Margulies - clinical molecular diagnostics
Elliott Margulies, Director of Bioinformatics at BillionToOne, discusses the application of molecular diagnostics to clinical testing. The Bioinformatics CRO is a fully distributed contract research company that serves the computational bio
Deniz Kavi - software for molecular design
Deniz Kavi, CEO of Tamarind Bio, discusses building a company and how to make great software for life scientists. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academi
Zahra Jawad - tumour antibody penetration
Dr. Zahra Jawad, founder and CEO of Creasallis, discusses antibody engineering and innovation to improve antibody penetration of solid tumours. The Bioinformatics CRO is a fully distributed contract research company that serves the computat
Jason Mellad - precision immunology
Jason Mellad, co-founder and CEO of OtoImmune, discusses his vision for leveraging personalised, precision immunology to better understand immune and autoimmune conditions. The Bioinformatics CRO is a fully distributed contract research com
Eric Green - genomic medicine
Dr. Eric Green, CMO at Illumina and former Director of the National Human Genome Research Institute, discusses the history of the Human Genome Project, his time at the NHGRI, and his new role at Illumina. The Bioinformatics CRO is a fully d
Jenny Yang - computable microbiomes
Jenny Yang, co-founder and CEO of Outpost Bio, discusses her work at the intersection of biology, machine learning, and precision medicine. The Bioinformatics CRO is a fully distributed contract research company that serves the computationa
Manuel Corpas - ClawBio and AI in bioinformatics
Dr. Manuel Corpas, founder of Cambridge Precision Medicine and originator of ClawBio, discusses his experience as a genomicist, entrepreneur and educator working at the intersection of genomics, AI, and health data science. The Bioinformati
John Connolly - cancer immunotherapy
John Connolly, CSO at the Parker Institute for Cancer Immunotherapy, discusses immuno-oncology and PICI's approach to funding groundbreaking cancer immunotherapy research. The Bioinformatics CRO is a fully distributed contract research comp
Diane Shao - neurology and neurogenetics
Dr. Diane Shao, an attending neurologist at Boston Children's Hospital and instructor of neurology at Harvard Medical School, discusses her work as a physician scientist focusing on genetic causes of childhood neurodevelopmental conditions.
Yang Li - gene regulation and RNA splicing
Yang Li, an Associate Professor at the University of Chicago, discusses applying computational genomics to the intersection of genetics, gene regulation, and disease, as well as the impact of new AI tools. The Bioinformatics CRO is a fully
Sun-Gou Ji - computational genomics for drug development
Dr. Sun-Gou Ji, statistical geneticist and VP of Computational Genomics at BridgeBio, discusses his career in genetics and genomics and BridgeBio's approach to target validation and novel target discovery. The Bioinformatics CRO is a fully
Ewelina Kurtys - wetware computing
Dr. Ewelina Kurtys, a neuroscientist at FinalSpark, discusses her experience bridging AI, neurotech, and business development in industry, and FinalSpark's mission to build a remotely accessible platform using living neural networks as a bi
Christopher Woelk - search & evaluation in biopharma
Christopher Woelk, an External Innovation Partner at Astellas, discusses his background in multi-omics and AI/ML and what he looks for in his current search & evaluation role embedded within therapeutic oncology research. The Bioinformatics
Chris Yohn - bridging computational biology and the wet lab
Chris Yohn, leader of CompBio Bridge, discusses his current experience with computational biology contracting and consulting, what companies are doing with computational biology right now, and how to most effectively bridge the gap between
Phillip Meade - building high-performance culture
Dr. Phillip Meade, a leadership and culture advisor at Gallaher Edge, discusses his experience evaluating organizational culture and how to diagnose culture problems and build lasting habits for high-performance organizations. The Bioinform
Nataraj Pagadala - molecular glues for targeted protein degradation
Nataraj Pagadala, founder, president, and CEO of LigronBio, discusses his company's goal of using molecular glues to target traditionally undruggable proteins as a route to new therapies for neurodegenerative diseases. The Bioinformatics CR
Sophia George - hereditary breast and ovarian cancer
Sophia George, professor in the Division of Gynecological Oncology at the University of Miami Miller School of Medicine, discusses her research at the Sylvester Comprehensive Cancer Center investigating the genetics and biology of hereditar
Christiaan Engstrom - building life sciences partnering networks
Christiaan Engstrom, founder and CEO of BLPN, discusses his experience building a space for authentic, non-transactional business networking in the life sciences. The Bioinformatics CRO is a fully distributed contract research company that
Joanne Hackett - revolutionising the future of healthcare
Dr. Joanne Hackett, VP of Health Systems Services at IQVIA and Chair of the Board at eLife, discusses her hopes for the future of healthcare. The Bioinformatics CRO is a fully distributed contract research company that serves the computatio
David Scieszka - senolytic vaccines to extend healthspan
David Scieszka, founder and CEO of Vertical Longevity Pharmaceuticals, tells us about VeLo's pioneering senolytic vaccine approach to clearing senescent cells and his quest for longer, healthier lives for everyone. The Bioinformatics CRO is
Caspar Barnes - blockchain infrastructure for biobanking
Caspar Barnes, founder and CEO of AminoChain, tell us about his mission to make biospecimen sourcing transparent, ethical, and efficient. The Bioinformatics CRO is a fully distributed contract research company that serves the computational
